
	



<!--
-->
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head xmlns=""><META http-equiv="Content-Type" content="text/html; charset=utf-8"><title>Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70 - Nature Cell Biology</title><meta name="description" content="Nature cell biology is a science journal containing cell biology articles and research papers on cell division, cell structure, animal and plant cell biology and cell cycles." />
<meta name="keywords" content="Nature cell biology, biology articles, cell signalling, cell structure biology, stem cell research, nature, stem cells, animal cells, plant cells, science fairs, cell biology, articles on biology, journal of cell biology, creative labs, science experiments, human anatomy, science news, science articles, science magazines, cell membranes, adipose tissue, science and nature, animal cell biology, microbiology, muscular physiology, molecular cell biology, biochem, molecular biology of the cell, laboratory, labs, red blood cells, female anatomy, science journals, science labs, anatomy and physiology, science and technology, apoptosis, nature magazines, molecular biology, protein synthesis, science news articles, plasma membranes, biology news, cell division, cell cycles, receptor mediated, lighting microscopy, plant cell biology." /><meta content="noarchive" name="robots"><link href="http://www.nature.com/favicon.ico" rel="shortcut icon"><link type="text/css" href="/ncb/style_older.css" rel="stylesheet"><style media="all" type="text/css">@import "/ncb/style.css";</style>
<script type="text/javascript" language="javascript"><!--
	var include = ';;;;';
	var adinf = "lg=no;";

	if(include != ";;;;")
	{
		adinf = include;
	}

	var time = new Date();
	ordval= (time.getTime());

//-->

var thisIssue = '/ncb/journal/v5/n4';




// provides cross-browser functionality
//======================================
function getObject(name) {
  if(document.getElementById) return document.getElementById(name);
  else if(document.all) return document.all[name];
  else return null;
}

function getIssueText(){
	if (isCurrent()) {
		return 'Current issue';
	} else {
		return 'Archive';
	}
}

function getIssueBreadcrumbText(){
	if (isCurrent()) {
		return 'Current issue';
	} else {
		return 'Table of Contents';
	}
}

function setTitleImg(){
	var titleImg = getObject('titleImg');
	if (titleImg){
		titleImg.alt = getIssueText();
	}
}

</script><script src="/mailafriend/mailafriend.js" language="javascript" type="text/javascript"></script><script LANGUAGE="JavaScript">
var currentIssue = '/ncb/journal/v6/n8';

function isCurrent(){

	//check for archive content
	if (currentIssue == thisIssue){
		return true;
	} else {
		return false;
	}
}
</script></head><body marginheight="0" marginwidth="0" topmargin="0" leftmargin="0" text="#000000" bgcolor="#FFFFFF"><a name="top"/><!-- start npg global nav -->
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr> 
<td align="center" bgcolor="#CCCCCC"> 
<table width="760" border="0" cellspacing="0" cellpadding="0">
<tr> 
<td width="34" height="37"><a href="http://npg.nature.com/npg/servlet/Content?data=xml/02_welcome.xml&amp;style=xml/02_welcome.xsl"><img src="/includes/rj_globnavimages/npg_header_logo.gif" width="26" height="26" alt="Nature Publishing Group, publisher of Nature, and other science journals and reference works" border="0" /></a></td>
<td width="7" align="left"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td align="center"><a href="http://www.nature.com" class="topnav">NATURE.COM</a></td>
<td width="14" align="center"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td align="center"><a href="/news/" class="topnav">NEWS@NATURE.COM</a></td>
<td width="14" align="center"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td align="center"><a href="/naturejobs/" class="topnav">NATUREJOBS</a></td>
<td width="14" align="center"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td align="center"><a href="/nature-events/" class="topnav">NATUREEVENTS</a></td>
<td width="14" align="center"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td align="center"><a href="http://npg.nature.com/npg/servlet/Content?data=xml/02_welcome.xml&amp;style=xml/02_welcome.xsl" class="topnav">ABOUT&#160;NPG</a></td>
<td width="14" align="center"><img src="/includes/rj_globnavimages/global_divider.gif" width="2" height="13" alt="" /></td>
<td width="6" align="center"><img src="/includes/rj_globnavimages/spacer.gif" width="6" height="13" alt="" /></td>
<td align="right"> 
<table width="192" border="0" cellspacing="0" cellpadding="0">
<tr> 
<td width="16"><a href="http://npg.nature.com/npg/servlet/Content?data=xml/02_welcome.xml&amp;style=xml/02_welcome.xsl"><img src="/includes/rj_globnavimages/help.gif" width="13" height="13" alt="help" border="0" /></a></td>
<td><a href="http://npg.nature.com/npg/servlet/Content?data=xml/08_help.xml&amp;style=xml/08_help.xsl" class="topnavsml">Help</a></td>
<td width="7" align="center"><img src="/includes/rj_globnavimages/spacer.gif" width="8" height="8" alt="" /></td>
<td width="16"><a href="/siteindex/"><img src="/includes/rj_globnavimages/siteindex.gif" width="12" height="12" border="0" alt="site index" /></a></td>
<td><a href="/siteindex/" class="topnavsml">Nature.com&#160;site&#160;index</a></td>
<td>&#160;</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td align="center" bgcolor="#000000" height="1"><img src="/includes/rj_globnavimages/spacer.gif" width="1" height="1" alt="" /></td>
</tr>
</table>
<!-- end global nav--><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td align="center" bgcolor="#546D9F"><table cellpadding="0" cellspacing="0" border="0" width="760" bgcolor="#546D9F"><tr height="74"><td width="161" align="left"><a href="/ncb/"><img height="54" width="161" alt="Nature Cell Biology" border="0" src="/includes/rj_globnavimages/ncb_logo.gif"></a></td><td background="/includes/rj_globnavimages/ncb_bg_header.gif" width="100%" align="left"><img alt="" height="1" width="1" src="/includes/rj_globnavimages/spacer.gif"></td><td width="247" valign="bottom">	
	
<table width="247" height="100%" border="0" cellpadding="1" cellspacing="0" class="lgn_border">
<tr><td>
<table width="245" border="0" cellpadding="0" cellspacing="0" class="lgn_background">
<tr><td width="1"><img src="/images/spacer.gif" alt="" width="1" height="71" /></td>
<td>
<table width="244" border="0" cellpadding="0" cellspacing="0" class="lgn_background">
<form name="login" method="post" action="/login/login.taf?_action=form2&login_return=true&_UserReference=C0A804EF4651D11F4B6FEB914ACD41114204">
<tr height="10" valign="top">
<td width="2"><img src="/images/spacer.gif" alt="" width="2" height="10"/></td>
<td width="4"><img src="/images/spacer.gif" alt="" width="4" height="10"/></td>
<td width="91"><img src="/images/spacer.gif" alt="" width="91" height="10"/></td>
<td width="91"><img src="/images/spacer.gif" alt="" width="91" height="10"/></td>
<td width="56"><img src="/images/spacer.gif" alt="" width="56" height="10"/></td>
</tr>
			<tr valign="top" height="100%">
<td class="lgn_text" colspan="2">&nbsp;</td>
<td class="lgn_text" colspan="3">Full text access provided to:<br />
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span class="lgn_textbig"><b>Weill Cornell Medical Library</b></span></td>
</tr>
<tr>
<td colspan="5"><img src="/images/spacer.gif" alt="" width="245" height="3"/></td>
</tr>
<tr valign="top">
<td class="lgn_text" colspan="2">&nbsp;</td>
<td class="lgn_text" colspan="3">by: <span class="lgn_textalt"><b>Weill Cornell Medical Library</b></span></td>
</tr>

	<tr height="6"><td colspan="5"><img src="/images/spacer.gif" alt="" width="244" height="6"/></td></tr>
</form>
</table>
</td></tr>
</table>
</td></tr>
</table></td><td valign="bottom"></td></tr></table><tr><td height="1" bgcolor="#000000" align="center"><img alt="" height="1" width="100%" src="/includes/rj_globnavimages/spacer.gif"></td></tr></td></tr></table><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td height="30" valign="top" align="center"><table cellpadding="0" cellspacing="0" border="0" width="760"><tr><td height="30" width="459"><table cellpadding="0" cellspacing="0" border="0" width="459"><form target="_blank" method="post" action="/dynasearch/app/dynasearch.taf" name="f1"><tr><td height="30" width="133"><span class="search">SEARCH&nbsp;JOURNAL</span></td><td height="30" width="140"><input value="Exact" name="sp-w" type="hidden"><input value="search" name="_action" type="hidden"><input value="Any" name="sp-p" type="hidden"><input value="ncb" name="sp_k" type="hidden"><input style="margin-left:0px;margin-right:0px;font-family:verdana,arial,helvetica,sans-serif;width:140px;height:20px;" tabindex="5" size="8" name="search_fulltext" type="text"></td><td height="30" width="10"><img alt="" height="8" width="10" src="/includes/rj_globnavimages/spacer.gif"></td><td height="30" width="36"><input align="middle" alt="search Nature Cell Biology" border="0" height="19" tabindex="6" width="26" src="/includes/rj_globnavimages/ncb_searchgo.gif" name="submit" type="image"></td><td width="6"><img alt="" height="5" width="3" src="/ncb/images/arrow_blue.gif"></td><td width="134" height="30"><a target="_blank" class="adsearch" href="/dynasearch/app/dynasearch.taf?site_source=ncb">Advanced search</a></td></tr></form></table></td><td align="right" height="30" width="87"><a target="_blank" href="/registration/Modify_registration.taf?site_source=ncb"><img alt="my account" border="0" height="15" width="85" src="/includes/rj_globnavimages/myacct.gif"></a></td><td align="right" height="30" width="68"><a target="_blank" href="http://npg.nature.com/npg/servlet/Content?data=xml/08_account.xml&style=xml/08_account.xsl"><img alt="e-alerts" border="0" height="15" width="66" src="/includes/rj_globnavimages/ealert.gif"></a></td><td align="right" height="30" width="78"><a href="/registration/index.taf?site_source=ncb" target="_blank"><img alt="subscribe" border="0" height="15" width="76" src="/includes/rj_globnavimages/subscribe.gif"></a></td><td align="right" height="30" width="68"><a href="/registration/index.taf?site_source=ncb"><img alt="register" border="0" height="15" width="66" src="/includes/rj_globnavimages/register.gif"></a></td></tr><tr><td height="4" colspan="5" bgcolor="#546D9F"><img alt="" height="4" width="1" src="/images/spacer.gif"></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr xmlns=""><td valign="top" height="22" align="center"><table cellpadding="0" cellspacing="0" border="0" width="760"><tr><td height="22" bgcolor="#DFE9FD" width="145">&nbsp;</td><td align="left" width="630" height="22" bgcolor="#DFE9FD" class="breadcrumb"><a class="breadcrumblink" href="/ncb/index.html">Journal home</a>&nbsp;&gt;
<script LANGUAGE="JavaScript">
	if (!isCurrent()){
	document.write('<a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/archive/index.html">Archive</a>&nbsp;&gt;');
	}
</script>
<a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/index.html">
<script LANGUAGE="JavaScript">
	document.write(getIssueBreadcrumbText());
</script></a>&nbsp;&gt;&nbsp;<a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/index.html#le">Letter</a> &gt; Full text</td></tr></table></td></tr><tr><td align="center"><table cellpadding="0" cellspacing="0" border="0" width="760"><tr><td valign="top" width="130"><input xmlns="" value="issue" id="leftnav_type" type="hidden"><input xmlns="" value="le" id="categ" type="hidden"><input xmlns="" value="" id="arch_categ" type="hidden"><script LANGUAGE="JavaScript">
var bgColorOn = "#546D9F";
var bgColor2 = "#EAEAEA";
//var bgClassOn = "leftnavOn_bg";
var imageOn = "/includes/rj_globnavimages/nav_dots1.gif";
var imageOff = "/includes/rj_globnavimages/nav_dots2.gif";
var imageSpacer = "/includes/rj_globnavimages/spacer.gif";

var issueType = 'issue';
var archiveType = 'archive';

var children = new Array();

function addSubLevel(parent, child){
	children[parent] = child;
}

function getObjectRef(name) {
  if(document.getElementById) return document.getElementById(name);
  else if(document.all) return document.all[name];
  else return null;
}

var thisPageType = '';

function setPageType(){
	var type = getObjectRef("leftnav_type").value;
	//alert(type);

	if (type == null){
		type = '';
	}

	//check for archive content
	if (type == issueType && !isCurrent()){
		type = archiveType;
	}

	thisPageType = type;
}

function getPageType(){
	return thisPageType;
}

setPageType();

function isCurrentType(thisType){
	if (thisType == getPageType()){
		return true;
	}else{
		var isChild = false;
		if (typeof children[thisType] != "undefined"){
			var child = children[thisType];
			for (var i=0; i<child.length; i++){
				if (getPageType() == child[i]){
					isChild = true;
				}
			}
		}
		return isChild;
	}
}

function getNewSubRow(name, linkhref, text){
	return '<tr><td width="5" style="background-color:'+bgColor2+'" id="'+name+'_1"><img src="'+imageSpacer+'" width="5" height="15" alt=""></td><td style="background-color:'+bgColor2+'" id="'+name+'_2" valign="top"><img src="'+imageOff+'" id="'+name+'_image" width="5" height="7" alt="" vspace="2"></td><td style="background-color:'+bgColor2+'" id="'+name+'_3"><img src="'+imageSpacer+'" width="5" height="15" alt=""></td><td style="background-color:'+bgColor2+'" id="'+name+'_4"><a href="'+linkhref+'" class="leftnav3" id="'+name+'_link">'+text+'</a></td><td width="5" style="background-color:'+bgColor2+'" id="'+name+'_5" valign="top"><img src="'+imageSpacer+'" width="5" height="15" alt=""></td></tr>';
}

function getSubRow(newRows){
	if (newRows != ''){
		return '<img src="'+imageSpacer+'" width="5" height="1" alt=""></td></tr><tr><td height="1" colspan="3"><table width="100%" cellpadding="0" cellspacing="0" border="0">'+newRows+'</table><tr><td colspan="3" height="1"><img src="'+imageSpacer+'" width="5" height="1" alt=""></td></tr>'
	} else {
		//return '<img src="'+imageSpacer+'" width="5" height="1" alt="">';
		return '';
	}
}

function hilite(text) {
// set colors

//alert(getObjectRef(text+"_1").style.backgroundColor);
	if (getObjectRef(text+"_link") != null){

		var num = 1;
		while (getObjectRef(text+"_"+num)){
			//getObjectRef(text+"_"+num).className  = bgClassOn;
			getObjectRef(text+"_"+num).style.backgroundColor = bgColorOn;
			num++;
		}

		getObjectRef(text+"_link").className = getObjectRef(text+"_link").className+"On";
	}

	if (getObjectRef(text+"_image") != null){
		//alert(getObjectRef(text+"_image").src);
		getObjectRef(text+"_image").src = imageOn;
	}

}

</script><table cellpadding="0" cellspacing="0" border="0" width="130"><tr><td height="1" colspan="3"><img alt="" height="1" width="5" src="/images/spacer.gif"></td></tr><tr><td id="home_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="home_2" style="background-color:
#DFE9FD"><a class="leftnav" href="/ncb/index.html" id="home_link">Journal home</a></td><td id="home_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="aop_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="aop_2" style="background-color:
#DFE9FD"><a class="leftnav" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/vaop/ncurrent/index.html" id="aop_link">Advance online publication</a></td><td id="aop_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"><script LANGUAGE="JavaScript">

var thisType = 'aop';

addSubLevel(thisType, new Array("About_AOP"));

var newRows = '';
if (isCurrentType(thisType) || '' == 'true'){

	
	newRows += getNewSubRow('About_AOP', '/ncb/aop/index.html', 'About AOP');
		

	if (isCurrentType(thisType) && thisType != getPageType()){
		hilite(thisType);
	}

}

document.write (getSubRow(newRows));
</script></td></tr><tr><td id="issue_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="issue_2" style="background-color:
#DFE9FD"><a class="leftnav" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v6/n7/index.html" id="issue_link">
Current issue
</a></td><td id="issue_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="archive_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="archive_2" style="background-color:
#DFE9FD"><a class="leftnav" href="/cgi-taf/DynaPage.taf?file=/ncb/archive/index.html" id="archive_link">Archive</a></td><td id="archive_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Press_releases_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Press_releases_2" style="background-color:
#DFE9FD"><a class="leftnav" href="/ncb/press_release/index.html" id="Press_releases_link">Press releases</a></td><td id="Press_releases_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr></table>
<table cellpadding="0" cellspacing="0" border="0" width="130"><tr><td height="1" colspan="3"><img alt="" height="1" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td id="Supplements_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Supplements_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/supplements/index.html" id="Supplements_link">Supplements</a></td><td id="Supplements_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Web_Focuses_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Web_Focuses_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/webfocus/index.html" id="Web_Focuses_link">Focuses</a></td><td id="Web_Focuses_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Cell_of_the_month_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Cell_of_the_month_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/image/index.html" id="Cell_of_the_month_link">Cell of the month</a></td><td id="Cell_of_the_month_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr></table>
<table cellpadding="0" cellspacing="0" border="0" width="130"><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td id="For_authors_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="For_authors_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/authors/index.html" id="For_authors_link">For authors</a></td><td id="For_authors_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"><script LANGUAGE="JavaScript">

var thisType = 'For_authors';

addSubLevel(thisType, new Array("How_to_submit","Content_types","Editorial_process"));

var newRows = '';
if (isCurrentType(thisType) || '' == 'true'){

	
	newRows += getNewSubRow('How_to_submit', '/ncb/authors/submit/index.html', 'How to submit');
	
	newRows += getNewSubRow('Content_types', '/ncb/authors/article_types/index.html', 'Content types');
	
	newRows += getNewSubRow('Editorial_process', '/ncb/authors/ed_process/index.html', 'Editorial process');
		

	if (isCurrentType(thisType) && thisType != getPageType()){
		hilite(thisType);
	}

}

document.write (getSubRow(newRows));
</script></td></tr><tr><td id="Online submission_1" style="background-color:#DFE9FD" colspan="3"><table cellpadding="0" cellspacing="0" border="0" width="130"><tr><td height="20"><img id="Online_submission_navimage" alt="Online submission" border="0" align="absmiddle" src="/includes/rj_globnavimages/ncb_icon_onlinesub.gif"></td><td><a class="leftnav2" href="http://mts-ncb.nature.com" target="_blank" id="Online_submission_link">Online submission</a></td></tr></table></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Permissions_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Permissions_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="http://npg.nature.com/npg/servlet/Content?data=xml/01_reprints.xml&amp;style=xml/01_reprints.xsl" target="_blank" id="Permissions_link">Permissions</a></td><td id="Permissions_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/images/spacer.gif"></td></tr><tr><td id="For_referees_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="For_referees_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/referees/index.html" id="For_referees_link">For referees</a></td><td id="For_referees_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/images/spacer.gif"></td></tr><tr><td id="sample_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="sample_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v6/n1/index.html" id="sample_link">Free online issue</a></td><td id="sample_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/images/spacer.gif"></td></tr><tr><td id="About_the_journal_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="About_the_journal_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/about/index.html" id="About_the_journal_link">About the journal</a></td><td id="About_the_journal_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"><script LANGUAGE="JavaScript">

var thisType = 'About_the_journal';

addSubLevel(thisType, new Array("About_the_editors","Editorial_policies","Masthead"));

var newRows = '';
if (isCurrentType(thisType) || '' == 'true'){

	
	newRows += getNewSubRow('About_the_editors', '/ncb/about/about_eds/index.html', 'About the editors');
	
	newRows += getNewSubRow('Editorial_policies', '/ncb/about/ed_policies/index.html', 'Editorial policies');
	
	newRows += getNewSubRow('Masthead', '/ncb/about/masthead/index.html', 'Masthead');
		

	if (isCurrentType(thisType) && thisType != getPageType()){
		hilite(thisType);
	}

}

document.write (getSubRow(newRows));
</script></td></tr><tr><td id="Contact_the_journal_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Contact_the_journal_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/contact/index.html" id="Contact_the_journal_link">Contact the journal</a></td><td id="Contact_the_journal_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Subscribe_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Subscribe_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/registration/index.taf?site_source=ncb" target="_blank" id="Subscribe_link">Subscribe</a></td><td id="Subscribe_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Advertising_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Advertising_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="http://advertising.nature.com" target="_blank" id="Advertising_link">Advertising</a></td><td id="Advertising_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Work_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Work_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="http://npg.nature.com/npg/forms/03_current.jsp" id="Work_link">work@npg</a></td><td id="Work_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="Reprints_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="Reprints_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="http://www.naturereprints.com" target="_blank" id="Reprints_link">naturereprints</a></td><td id="Reprints_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td id="About_this_site_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="About_this_site_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="/ncb/site/index.html" id="About_this_site_link">About this site</a></td><td id="About_this_site_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr><tr><td height="12" colspan="3"><img alt="" height="12" width="5" src="/images/spacer.gif"></td></tr><tr><td id="For_librarians_1" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td><td id="For_librarians_2" style="background-color:
#DFE9FD"><a class="leftnav2" href="http://npg.nature.com/npg/servlet/Content?data=xml/07_home.xml&amp;style=xml/07_home.xsl" target="_blank" id="For_librarians_link">For librarians</a></td><td id="For_librarians_3" width="5" style="background-color:
#DFE9FD"><img alt="" height="20" width="5" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td height="1" colspan="3"></td></tr></table>
<script LANGUAGE="JavaScript">
	hilite(getPageType());
</script></td><td width="15"><img alt="" height="1" width="15" src="/images/spacer.gif"/></td><td width="470" valign="top"><table cellpadding="0" cellspacing="0" border="0" width="470"><tr xmlns=""><td valign="top" height="21"><img alt="" height="21" width="1" src="/images/spacer.gif"></td></tr><tr xmlns=""><td valign="top" height="22"><span class="categ_large">Letter</span></td></tr><tr xmlns=""><td><img alt="" height="1" width="470" src="/ncb/images/spacer_grey.gif"></td></tr><tr xmlns=""><td height="14"><img alt="" height="14" width="1" src="/images/spacer.gif"></td></tr><tr><td><span xmlns="" class="blacksml"><i>Nature Cell Biology</i>
&nbsp;<b>5</b>, 352 - 357 (2003)
 <br>Published online: 24&nbsp;March&nbsp;2003;  | doi:10.1038/ncb955
</span><h2 xmlns="">Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70</h2><span xmlns="" class="author">Motoshi Sawada, Paulette Hayes
&amp;&nbsp;Shigemi Matsuyama<p class="blacksml">Blood Research Institute, The Blood Center of South Eastern Wisconsin and Department of Biochemistry, Medical College of Wisconsin 8727 Watertown Plank Rd, Milwaukee WI 53226</p><span class="blacksml">
Correspondence should be addressed to Shigemi Matsuyama <a href="mailto:smatsuyama@bcsew.edu">smatsuyama@bcsew.edu</a></span></span><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="470"><tr><td height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr><tr><td height="1"><img alt="" height="1" width="470" src="/ncb/images/spacer_grey.gif"></td></tr><tr><td height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr></table><a xmlns="" name="abstract"></a><span xmlns="" class="articletext"><b>Bax is a pro-apoptotic member of Bcl-2 family proteins and is central to mitochondria-dependent apoptosis<sup><a href="#B1">1, 
</a></sup><sup><a href="#B2">2, 
</a></sup><sup><a href="#B3">3</a></sup>. Bax resides in the cytosol as a quiescent protein and translocates into mitochondria after apoptotic stimuli<sup><a href="#B4">4</a></sup>. Ku70 is a 70K subunit of the Ku complex, which has an important role in DNA double-strand break (DSB) repair in the nucleus<sup><a href="#B5">5</a></sup>. In another article in this issue, we reported that Ku70 interacts with pro-apoptotic protein Bax in the cytosol and prevents its mitochondrial translocation<sup><a href="#B6">6</a></sup>, suggesting that Ku70 suppresses Bax-mediated apoptosis. Here, we describe the development of a new membrane-permeable peptide, Bax-inhibiting peptide (BIP) that inhibits Bax-mediated apoptosis, on the basis of the previous finding that showed an interaction between Ku70 and Bax. BIP is comprised of five amino acids designed from the Bax-binding domain of Ku70, and suppresses the mitochondrial translocation of Bax. BIP inhibited Bax-mediated apoptosis induced by staurosporine, UVC irradiation and anti-cancer drugs in several types of cells. BIP may provide valuable information in the development of therapeutics that control apoptosis-related diseases.<br><br></b></span><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="450"><tr><td height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr><tr><td height="1"><img alt="" height="1" width="450" src="/ncb/images/spacer_grey.gif"></td></tr><tr><td height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">We reported that the carboxy-terminal 74 amino acids of Ku70 are sufficient to bind Bax and to inhibit Bax-mediated apoptosis in several cell types<sup><a href="#B6">6</a></sup>. Recent structural analysis of Ku70 revealed that the 74-amino-acid C-terminal portion is comprised of three <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">-helices and four flexible loop domains<sup><a href="#B5">5, 
</a></sup><sup><a href="#B7">7</a></sup> (<a href="#f1">Fig. 1a</a>). Further analysis of a series of deletion mutants of Ku70 revealed that the C-terminal 32 amino acids are sufficient to inhibit Bax-induced apoptosis in HEK293T cells (<a href="#f1">Fig. 1a&#150;c</a>). A Flag-tagged Ku70 mutant expressing amino acids 578&#150;609 of Ku70 (Ku70<sup>578&#150;609</sup>) bound to endogenous Bax, whereas a Ku70 mutant in which these amino acids have been deleted (Ku70<sup>1&#150;577</sup>) did not (<a href="#f1">Fig. 1b</a>). Furthermore, Ku70<sup>578&#150;609</sup>, but not Ku70<sup>1&#150;577</sup>, suppressed Bax-induced apoptosis in HEK293T cells (<a href="#f1">Fig. 1c</a>). These results suggest that the Bax-inhibiting domain is located between amino acids 578&#150;609 of Ku70.</span><br xmlns=""><br xmlns=""><a xmlns="" name="f1"></a><table xmlns="" cellpadding="10" cellspacing="0" border="0" width="470"><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="430"><tr><td class="articletext" colspan="2"><b><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F1.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F1.html">Figure&nbsp;1.</a>&nbsp;New peptides designed from Ku70 show anti-Bax activity.</b></td></tr><tr><td height="15"><img alt="" height="1" width="160" src="/images/spacer.gif"></td><td height="15"><img alt="" height="1" width="270" src="/images/spacer.gif"></td></tr><tr><td width="160" valign="top"><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F1.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F1.html"><img border="0" alt="Figure&nbsp;1 thumbnail" src="/ncb/journal/v5/n4/thumbs/ncb955-f1.gif"></a></td><td class="blacksml" width="270" valign="top"><p class="blacksml"><b>a</b>, A schematic representation of full-length Ku70 (Ku70<sup>wt</sup>), Ku70<sup>1&#150;577</sup> (Ku70<sup><img border=0 src="/__chars/_delta/black/med/small/glyph.gif" align="bottom" alt="Delta">578&#150;609</sup>) or Ku70<sup>578&#150;609</sup> (Ku70<sup><img border=0 src="/__chars/_delta/black/med/small/glyph.gif" align="bottom" alt="Delta">1&#150;577</sup>). <b>b</b>, HEK293T cells were transfected as indicated. One day after transfection, co-immunoprecipitation of Flag&#150;Ku70 and Bax was performed. <b>c</b>, HEK293T cells were transfected as indicated. Cells were also cotransfected with GFP to mark transfected cells. Apoptosis in transfected cells was analysed 24 h after transfection with Hoechst dye staining of the nucleus. <b>d</b>, HEK293T cells were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M peptide composed of Ku70<sup>578&#150;587</sup> or Ku70<sup>596&#150;600</sup> for 4 h using BioPorter reagent and then transfected with control vector or Bax. The number of apoptotic cells was determined as described in <b>c</b>. <b>e</b>, HEK293T cells were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M IPMIK (negative control peptide), VPMLK (V5) or PMLKE (P5) peptides at the indicated concentrations for 1 h. Next, cells were transfected with Bax. Peptides were added again in the fresh medium after removal of transfection reagents. Also, unincubated cells were transfected with Bax in the presence or absence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M z-VAD-fmk. The number of apoptotic cells was determined one day after transfection, as described in <b>c</b>. <b>f</b>, Summary of the anti-Bax activity and sequence of all peptides used.</p><br><br><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F1.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F1.html"><img border="0" align="bottom" alt="Full Figure" height="11" width="17" src="/ncb/images/fullsize_icon.gif"></a><a class="sml" onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F1.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F1.html">Full Figure and legend (80K)</a></td></tr></table></td></tr><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">Previous reports suggest that there are two <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">-helices in these 32 amino acids<sup><a href="#B5">5, 
</a></sup><sup><a href="#B7">7</a></sup> (<a href="#f1">Fig. 1a</a>). Synthetic peptides corresponding to these two <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">-helices were made and their ability to suppress Bax-induced apoptosis was examined (<a href="#f1">Fig. 1d</a>). As these peptides are not membrane-permeable, fluorescein isothiocyanate (FITC)-labelled peptides were delivered into cells by a liposome-mediated approach. The presence of the peptides in cells was confirmed by examining FITC fluorescence (data not shown). The peptide corresponding to amino acids 578&#150;587, but not 596&#150;600, inhibited Bax-induced apoptosis, suggesting that the Bax-inhibiting domain is located in the second <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">-helix from the C terminus of Ku70 (<a href="#f1">Fig. 1d</a>).</span><br xmlns=""><br xmlns=""><span xmlns="" class="articletext">Further analysis of the peptides designed from the Ku70 Bax-inhibiting domain revealed that six amino acids (VPMLKE; V6 peptide) in the Bax-inhibiting domain (amino acids 578&#150;587) of Ku70 is sufficient to suppress Bax-mediated apoptosis (through overexpression of Bax, staurosporine (STS) treatment or UVC-induced apoptosis; data not shown). However, the V6 peptide is not membrane-permeable and liposome-mediated delivery of the peptide is required to suppress Bax-mediated apoptosis. Interestingly, the deletion of one amino acid from either the N or C terminus of VPMLKE made these peptides membrane-permeable and did not abrogate their Bax-inhibiting activity (<a href="#f1">Fig. 1e, f</a>). In fact, the five-amino-acid peptides VPMLK (V5) and PMLKE (P5) were equally effective in suppressing apoptosis induced by overexpression of Bax (see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S1</a>, for FACS analysis). As V5 and P5 are membrane-permeable, addition of these peptides into the culture medium is sufficient to block Bax-mediated apoptosis. However, further deletion of one amino acid resulted in the abrogation of Bax-inhibiting activity (<a href="#f1">Fig. 1f</a>). Both PMLK (P4) and MLKE (M4) could not suppress Bax-mediated apoptosis (data not shown). In addition, when the Val and Leu residues in the V5 peptide (VPMLK) were changed to Ile, another non-polar amino acid, the peptide (IPMIK) lost its ability to suppress apoptosis, although it retained membrane permeability (<a href="#f1">Fig. 1e, f</a>). The mutant peptide IPMIK was used as a negative control (NC) peptide in subsequent experiments.</span><br xmlns=""><br xmlns=""><span xmlns="" class="articletext">The BIP peptides had anti-apoptotic activities at 50&#150;200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M (<a href="#f1">Fig. 1e</a>), and therefore function as effectively as the caspase inhibitor z-VAD-fmk. Pretreatment of HeLa cells with BIP peptides for 1 h was sufficient to provide protection from STS- and UVC-induced apoptosis (<a href="#f2">Fig. 2a, b</a>). It should also be noted that BIPs were both stable and functional for at least three days in the culture medium (<a href="#f2">Fig. 2a, b</a>). BIP did not enhance z-VAD-fmk-mediated suppression of apoptosis induced by UVC irradiation (<a href="#f2">Fig. 2c</a>) or STS treatment (data not shown). As Bax functions upstream of caspase activation, BIP may not be able to show the additive effects to the caspase inhibitor. BIPs also suppressed apoptosis induced by the anti-cancer drugs etoposide, cisplatin and doxorubicin in several types of cancer cell lines, including glioma cells (U87-MG; <a href="#f2">Fig. 2d&#150;f</a>), breast cancer cells (MCF-7) and prostate cancer cells (LNCaP; see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S2a&#150;f</a>). To confirm that BIP specifically suppresses Bax-mediated apoptosis, the effects of BIPs in Bax-deficient cells (DU145) were examined. BIPs did not suppress STS- or UVC-induced apoptosis in DU145 cells, whereas BIP showed anti-apoptotic activity in these cells when non-toxic levels of Bax expression were restored by plasmid transfection (<a href="#f2">Fig. 2g, h</a> and see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Figs S2g, h</a> and <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">S3a, b</a>). This suggests that BIP specifically inhibits the Bax-mediated signal in apoptosis. These results are consistent with the observations that Ku70 does not confer cytoprotection against STS treatment or UVC irradiation in Bax-deficient cells, and that Ku70 does not block Bak-induced apoptosis<sup><a href="#B6">6</a></sup>. Furthermore, BIPs did not suppress Fas- and TRAIL-induced apoptosis (data not shown). Fas and TRAIL can trigger the mitochondria-independent cell death pathway<sup><a href="#B8">8, 
</a></sup><sup><a href="#B9">9</a></sup>; therefore, BIP may not be able to suppress apoptosis induced by these factors. These results suggest that BIP only suppresses Bax-mediated apoptosis. However, BIP suppressed STS- and UVC-induced apoptosis in Ku70-deficient mouse embryonic fibroblasts (MEFs), suggesting that BIP does not require endogenous Ku70 to suppress Bax-mediated apoptosis (<a href="#f2">Fig. 2i, j</a>)</span><br xmlns=""><br xmlns=""><a xmlns="" name="f2"></a><table xmlns="" cellpadding="10" cellspacing="0" border="0" width="470"><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="430"><tr><td class="articletext" colspan="2"><b><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F2.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F2.html">Figure&nbsp;2.</a>&nbsp;Inhibitory effects of BIP against various apoptotic stimuli.</b></td></tr><tr><td height="15"><img alt="" height="1" width="160" src="/images/spacer.gif"></td><td height="15"><img alt="" height="1" width="270" src="/images/spacer.gif"></td></tr><tr><td width="160" valign="top"><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F2.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F2.html"><img border="0" alt="Figure&nbsp;2 thumbnail" src="/ncb/journal/v5/n4/thumbs/ncb955-f2.gif"></a></td><td class="blacksml" width="270" valign="top"><p class="blacksml"><b>a</b>, <b>b</b>, HeLa cells were pre-incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M negative control (NC) peptide for 1 h or V5 peptide for the indicated periods before treatment with 200 nM STS (<b>a</b>) or UVC irradiation (<b>b</b>). After a further 24 h, apoptotic cells were counted as described in <a href="#f1">Fig. 1</a>. <b>c</b>, HeLa cells were pre-incubated with V5 peptide and/or z-VAD-fmk at the indicated concentrations for 1 h before UVC irradiation. The number of apoptotic cells was determined one day after UVC irradiation, as described in <a href="#f1">Fig. 1</a>. <b>d</b>&#150;<b>f</b>, U87-MG glioma cells were pre-incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide or V5 peptide at the indicated concentrations and then treated with 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M etoposide (<b>d</b>), 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M cisplatin (<b>e</b>) or 1 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M doxorubicin (<b>f</b>). Apoptotic cells were analysed at the indicated times after treatment with anti-cancer drugs, as described in <a href="#f1">Fig. 1</a>. Similar results were obtained in other cancer cell lines, such as MCF-7 and LNCaP cells (see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S2a&#150;f</a>). <b>g</b>, <b>h</b>, Effects of BIP in Bax-deficient cells. In DU145 cells were transfected as indicated. In Bax-transfected cells, non-toxic levels of Bax were expressed (see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S2g, h</a> and <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">S3a, b</a>). One day after transfection, cells were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide or V5 peptide for 1 h and then treated with 200 nM STS (<b>g</b>) or underwent UVC irradiation (<b>h</b>). After 24 h of apoptotic treatment, apoptotic cells were counted as described in <a href="#f1">Fig. 1</a>. <b>i</b>, <b>j</b>, BIP does not require Ku70 to suppress apoptosis. MEFs derived from <i>Ku70<sup>-/-</sup></i> mice were treated with 200 nM STS (<b>i</b>) or underwent UVC irradiation (<b>j</b>) in the presence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide or V5 peptide. Apoptotic cells were analysed at the indicated times after treatment with STS or UVC irradiation, as described in <a href="#f1">Fig. 1</a>.</p><br><br><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F2.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F2.html"><img border="0" align="bottom" alt="Full Figure" height="11" width="17" src="/ncb/images/fullsize_icon.gif"></a><a class="sml" onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F2.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F2.html">Full Figure and legend (92K)</a></td></tr></table></td></tr><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">BIP (V5) suppressed the mitochondrial translocation of Bax stimulated by STS treatment and UVC irradiation (<a href="#f3">Fig. 3a</a>) as efficiently as Ku70 (ref. <a href="#B6">6</a>). As we reported, apoptotic stimuli decrease Ku70 levels in the cytosol<sup><a href="#B6">6</a></sup>. BIP did not inhibit the disappearance of Ku70 from the cytosol (<a href="#f3">Fig. 3b</a>), suggesting that the anti-apoptotic activity of BIP is not caused by inhibiting the degradation of endogenous Ku70. The release of cytochrome <i>c</i> from mitochondria and caspase activation triggered by apoptotic stimuli were also significantly suppressed by BIP (<a href="#f3">Fig. 3c, d</a>), further supporting the hypothesis that BIP protects cells by inhibiting the Bax-mediated mitochondria-dependent apoptosis pathway. The interaction of BIP and Bax was confirmed by experiments using biotin-labelled BIP (biotin&#150;VPMLK) and streptavidin beads. Biotin&#150;VPMLK precipitated Bax from cell lysates when streptavidin beads were added to the samples (<a href="#f3">Fig. 3e</a>). In contrast, Bax was not precipitated when a negative control peptide (biotin&#150;IPMIK) was used, explaining why IPMIK (NC peptide in the figures) did not suppress Bax-mediated cell death. Furthermore, Bak was not precipitated by biotin&#150;VPMLK (see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S3c</a>). Scatchard analysis with FITC&#150;BIP (VPMLK) and endogenous Bax in Ku70-deficeint MEF cell lysates suggested that the BIP&#150;Bax interaction has a <i>K</i><sub>d</sub> of 1.3 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M (<a href="#f3">Fig. 3f</a>). Cells treated with FITC&#150;BIP (VPMLK) are shown (<a href="#f4">Fig. 4a, b</a>). FITC&#150;BIP was localized mostly in the cytosol in HeLa cells (<a href="#f4">Fig. 4a</a>), but was distributed in both the cytosol and the nucleus in Bax-deficient DU145 cells (<a href="#f4">Fig. 4b</a>). Expression of Bax in DU145 cells increased the cytosolic levels of FITC&#150;BIP (<a href="#f4">Fig. 4c&#150;f</a>), suggesting that BIP binds to cytosolic Bax. Colocalization of Bax and BIP was also observed in HeLa cells (<a href="#f4">Fig. 4g&#150;i</a>). These results further support the hypothesis that BIP inhibits Bax-mediated apoptosis by interacting with Bax in the cytosol. It has been suggested that the conformational change of Bax (exposure of the N terminus) occurs before its mitochondrial translocation<sup><a href="#B10">10</a></sup> and that Ku70 inhibits this event<sup><a href="#B6">6</a></sup>. The monoclonal antibody clone 6A7 is known to detect exposure of the Bax N terminus<sup><a href="#B11">11, 
</a></sup><sup><a href="#B12">12</a></sup>. BIP reduced the amount of Bax protein recognized by the 6A7 antibody in cells treated with apoptotic stimuli (<a href="#f4">Fig. 4j</a>), suggesting that similarly to Ku70, BIP inhibits the conformational change of Bax.</span><br xmlns=""><br xmlns=""><a xmlns="" name="f3"></a><table xmlns="" cellpadding="10" cellspacing="0" border="0" width="470"><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="430"><tr><td class="articletext" colspan="2"><b><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F3.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F3.html">Figure&nbsp;3.</a>&nbsp;BIP inhibits the mitochondrial translocation of Bax.</b></td></tr><tr><td height="15"><img alt="" height="1" width="160" src="/images/spacer.gif"></td><td height="15"><img alt="" height="1" width="270" src="/images/spacer.gif"></td></tr><tr><td width="160" valign="top"><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F3.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F3.html"><img border="0" alt="Figure&nbsp;3 thumbnail" src="/ncb/journal/v5/n4/thumbs/ncb955-f3.jpg"></a></td><td class="blacksml" width="270" valign="top"><p class="blacksml"><b>a</b>, Hela cells underwent UVCirradiation or STStreatment in the presence or absence of NC or V5 peptide. Subcellular fractionation of HeLa cells was then performed one day after the apoptotic treatment (see Methods). FoF1 ATP synthase subunit <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha"> (F1<img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">) was used as a marker for mitochondrial fraction. HM, heavy-membrane fraction containing mitochondria. <b>b</b>, HeLa cells were treated with 200 nM STS in the presence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide or V5 peptide, as indicated. One day after STS treatment, subcellular fractionation was performed and the levels of Ku70 and Bax were examined. Lactate dehydrogenase (LDH), proliferating cell nuclear antigen (PCNA) and F1<img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha"> were used as markers for cytosolic, nuclear and mitochondrial fractions, respectively. <b>c</b>, BIP inhibits cytochrome <i>c</i> release from mitochondria. HeLa cells were treated with 200 nM STS in the presence or absence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide, V5 peptide or z-VAD-fmk for 24 h. Mitochondrial cytochrome <i>c</i> release was analysed by western blotting. F1<img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha"> was used as a marker of the HM fraction. <b>d</b>, BIP suppresses caspase activation. HeLa cells were treated with 200 nM STS in the presence or absence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M NC peptide, V5 peptide or z-VAD-fmk for 24 h. Caspase activity was then assessed. RFU, relative fluorescence units. <b>e</b>, BIP binds to endogenous Bax. Coprecipitation of endogenous Bax and BIP. HEK293T cell lysates were incubated in the absence (no peptide) or presence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M biotin-labelled NC peptide and biotin-labelled V5 peptide at the indicated concentrations. Coprecipitation was performed with Streptavidin beads or anti-Bax polyclonal antibody. Western blot analyses of pre-precipitation (Input) and precipitated samples (IP) were performed with anti-Bax monoclonal antibody. <b>f</b>, Scatchard analysis. Scatchard analysis of the binding of FITC-labelled BIP (VPMLK) and endogenous Bax in Ku70-deficient MEFs was performed. The <i>K</i><sub>d</sub> was estimated to be 1.3 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M. B, bound; F, free.</p><br><br><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F3.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F3.html"><img border="0" align="bottom" alt="Full Figure" height="11" width="17" src="/ncb/images/fullsize_icon.gif"></a><a class="sml" onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F3.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F3.html">Full Figure and legend (113K)</a></td></tr></table></td></tr><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr></table><a xmlns="" name="f4"></a><table xmlns="" cellpadding="10" cellspacing="0" border="0" width="470"><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="430"><tr><td class="articletext" colspan="2"><b><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F4.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F4.html">Figure&nbsp;4.</a>&nbsp;BIP binds Bax <i>in vivo</i>.</b></td></tr><tr><td height="15"><img alt="" height="1" width="160" src="/images/spacer.gif"></td><td height="15"><img alt="" height="1" width="270" src="/images/spacer.gif"></td></tr><tr><td width="160" valign="top"><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F4.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F4.html"><img border="0" alt="Figure&nbsp;4 thumbnail" src="/ncb/journal/v5/n4/thumbs/ncb955-f4.jpg"></a></td><td class="blacksml" width="270" valign="top"><p class="blacksml"><b>a</b>, <b>b</b>, HeLa (<b>a</b>) or DU145 cells (<b>b</b>) were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M FITC&#150;V5 peptide for 1 h before analysis by immunofluorescence microscopy. Localization of FITC&#150;BIP changes in accordance with restoration of Bax level in Bax-deficient DU145 cells. <b>c</b>&#150;<b>f</b>, DU145 cells were transfected with control vector or Bax in the presence of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M FITC&#150;V5 peptide. After 24 h, cells were collected and the levels of Bax and <img border=0 src="/__chars/beta/black/med/base/glyph.gif" align="middle" alt="beta">-tubulin in total cell lysates were examined (<b>f</b>). Transfected cells were also immunostained with Bax and a Texas Red secondary antibody before analysis by immunofluorescence microscopy (<b>c, d</b>). A merged image is also shown (<b>e</b>). <b>g</b>&#150;<b>i</b>, HeLa cells were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M FITC&#150;V5 peptide (<b>g</b>) for 1 h and then Bax was immunostained with Texas-Red-labelled secondary antibody (<b>h</b>). Samples were then analysed by immunofluorescence microscopy. <b>j</b>, BIP suppresses the activation of Bax. HeLa cells underwent UVC irradiation and were either left untreated or treated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M negative control (NC) peptide or V5 peptide. One day after UVC irradiation, immunoprecipitation was performed with anti-Bax monoclonal antibody (clone 6A7) using Chaps buffer.</p><br><br><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F4.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F4.html"><img border="0" align="bottom" alt="Full Figure" height="11" width="17" src="/ncb/images/fullsize_icon.gif"></a><a class="sml" onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F4.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F4.html">Full Figure and legend (80K)</a></td></tr></table></td></tr><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">BIP (VPMLK (V5) and PMLKE (P5)) inhibited the interaction (co-immunoprecipitation) of endogenous Bax and Ku70 in a dose-dependent manner (<a href="#f5">Fig. 5a, b</a>). However, BIP did not interfere with the Ku70&#150;Ku80 interaction or with Bax&#150;Bcl-2 heterodimerization (see <a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html">Supplementary Information, Fig. S3d, e</a>). These results suggest that BIP specifically interacts with Bax through the Ku70-binding domain in Bax and that BIP competes with Ku70 to bind to Bax. Interestingly, addition of PMLK (P4) to cell lysates inhibited the interaction of Bax and Ku70 (<a href="#f5">Fig. 5c</a>), although PMLK (P4) could not suppress apoptosis in cell culture. In contrast, MLKE (M4) did not interfere with the Bax&#150;Ku70 interaction (<a href="#f5">Fig. 5d</a>). These results suggest that four amino acids of PMLK may be sufficient to bind to Bax, at least <i>in vitro</i>. We have shown that VPMLK and PMLKE can suppress Bax-induced apoptosis (<a href="#f1">Fig. 1</a>). Although further analysis is required, the reason why PMLK did not suppress apoptosis in culture may be because it is rapidly degraded or modified in living cells. It is also possible that addition of Val (N terminus) or Glu (C terminus) to PMLK may improve the membrane permeability or the cytosolic retention of the peptide. Future biochemical studies should answer this question.</span><br xmlns=""><br xmlns=""><a xmlns="" name="f5"></a><table xmlns="" cellpadding="10" cellspacing="0" border="0" width="470"><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="430"><tr><td class="articletext" colspan="2"><b><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F5.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F5.html">Figure&nbsp;5.</a>&nbsp;Ku70-derived peptides bind Bax and dissociate Ku70 from Bax.</b></td></tr><tr><td height="15"><img alt="" height="1" width="160" src="/images/spacer.gif"></td><td height="15"><img alt="" height="1" width="270" src="/images/spacer.gif"></td></tr><tr><td width="160" valign="top"><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F5.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F5.html"><img border="0" alt="Figure&nbsp;5 thumbnail" src="/ncb/journal/v5/n4/thumbs/ncb955-f5.jpg"></a></td><td class="blacksml" width="270" valign="top"><p class="blacksml"><b>a</b>&#150;<b>d</b>, HEK293T cells lysed in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Chaps buffer were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M negative control (NC) peptide or VPMLK (V5) (<b>a</b>), PMLKE (P5) (<b>b</b>), PMLK (P4) (<b>c</b>) or MLKE (M4) (<b>d</b>) at the indicated concentrations for 1 h. Immunoprecipitation was performed with anti-Ku70 monoclonal antibody or anti-Bax polyclonal antibody using Chaps buffer. Mouse IgG and pre-immune NRS were used as negative controls.</p><br><br><a onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F5.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F5.html"><img border="0" align="bottom" alt="Full Figure" height="11" width="17" src="/ncb/images/fullsize_icon.gif"></a><a class="sml" onclick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_F5.html','Figure_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,copyhistory=yes,width=617,top=20,left=20');return false;" href="/ncb/journal/v5/n4/fig_tab/ncb955_F5.html">Full Figure and legend (97K)</a></td></tr></table></td></tr><tr><td><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">In summary, we have developed membrane-permeable peptides (BIPs) from the Bax-binding domain of Ku70 that inhibit Bax-mediated apoptosis. We also found that BIP inhibits exposure of the Bax N terminus induced by apoptotic stimuli. However, the mechanism of Bax activation remains unclear. It may be possible to use BIP as a tool to elucidate the mechanism of the Bax conformational change. At present, it is unclear whether BIP can bind Bax directly. It remains possible that other factors are involved in this interaction. Future biochemical study to analyse complex formation of purified inactive Bax proteins and peptides may answer these questions. Bax-mediated cell death is known to be involved in several types of degenerative diseases and in the loss of viability of cultured cells<sup><a href="#B13">13, 
</a></sup><sup><a href="#B14">14, 
</a></sup><sup><a href="#B15">15</a></sup>. The membrane-permeable Bax-inhibiting peptide developed in this study may provide the valuable information required for the development of new therapeutics to control apoptosis-related diseases.</span><br xmlns=""><br xmlns=""><a xmlns="" name="Methods"></a><span xmlns="" class="heading3">Methods</span><br xmlns=""><a xmlns="" name="Cell culture and detection of apoptosis"></a><span xmlns="" class="articletext"><b>Cell culture and detection of apoptosis</b></span><br xmlns=""><span xmlns="" class="articletext">HEK293T and HeLa cells were cultured in MEM supplemented with 10% foetal bovine serum (FBS). MEFs and DU145 cells were cultured in DMEM supplemented with 10% FBS. Transfections were performed with SuperFect (Qiagen, Valencia, CA) in accordance with the manufacturer's instructions. Apoptosis was induced by Bax overexpression (1 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of pcDNA3-human Bax for 10<sup>6</sup> HEK293T cells), STS treatment (200 nM for HeLa cells) or UVC irradiation (600 J m<sup>-2</sup> for HeLa cells and 1,200 J m<sup>-2</sup> for DU145 cells). To examine anti-apoptotic activity of Flag&#150;Ku70 (wild type and mutant), 1 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of Bax plasmid and 2 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of Flag&#150;Ku70 (wild type and mutant) plasmid were cotransfected into 10<sup>6</sup> HEK293T cells. One day after transfection, apoptosis was analysed. Apoptosis in transfected cells was analysed as follows: a plasmid encoding green fluorescent protein (GFP; 0.5 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g for 10<sup>6</sup> cells) was transfected into all the groups to mark transfected cells. After treatment, cells were stained with Hoechst dye and cells with apoptotic nuclei were counted in GFP-expressing cells under a fluorescence microscope, as previously described<sup><a href="#B14">14</a></sup>. Each point in the figures showing percentages of apoptosis represents the mean <img border=0 src="/__chars/plus/special/plusmn/black/med/base/glyph.gif" align="bottom">s.e.m. of three experiments. Caspase activities of cells were measured by detecting cleavage of the fluorogenic caspase substrate, DEVD-amino-4-trifluoromethylcoumarin (DEVD-afc), as previously described<sup><a href="#B11">11</a></sup>.</span><br xmlns=""><br xmlns=""><a xmlns="" name="Plasmids"></a><span xmlns="" class="articletext"><b>Plasmids</b></span><br xmlns=""><span xmlns="" class="articletext">The plasmid pcDNA3-Bax (human) has been described<sup><a href="#B6">6</a></sup>. The plasmid vectors pCMV-2B and pEGFP were purchased from Stratagene (Cedar Creek, TX) and Clontech (Palo Alto, CA), respectively, and human full-length Ku70 and the deletion mutants of Ku70 were subcloned into the <i>Bam</i>HI and <i>Xho</i>I sites of pCMV-2B vector. The deletion mutants of Bax were subcloned into <i>Eco</i>RI and <i>Sal</i>I sites of pEGFP plasmid. The full-length Ku70 cDNA was prepared by RT-PCR using HeLa cell cDNA<sup><a href="#B6">6</a></sup>. The mutant constructs of Ku70 described were prepared by the second step PCR mutagenesis method<sup><a href="#B6">6</a></sup>.</span><br xmlns=""><br xmlns=""><a xmlns="" name="Delivery of peptide into cells"></a><span xmlns="" class="articletext"><b>Delivery of peptide into cells</b></span><br xmlns=""><span xmlns="" class="articletext">For the membrane-permeable peptide, the stock solution was prepared in PBS and the peptides were added directly into medium at 37 &#176;C for 1 h (or for the indicated periods (<a href="#f2">Fig. 2a, b</a>)) before apoptosis-inducing treatment. Non-membrane-permeable peptide was delivered into cells using the BioPorter reagent (Gene Therapy Systems, San Diego, CA) according to the manufacturer's instructions. BioPorter-based peptide delivery was performed 4 h before apoptosis-inducing treatment.</span><br xmlns=""><br xmlns=""><a xmlns="" name="Cytochrome c detection"></a><span xmlns="" class="articletext"><b>Cytochrome <i>c</i> detection</b></span><br xmlns=""><span xmlns="" class="articletext">One day after transfection, STS treatment or UVC irradiation, cells were resuspended in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of homogenization buffer (250 mM sucrose, 20 mM Hepes at pH 7.5, 10 mM potassium chloride, 1.5 mM magnesium chloride, 1 mM EDTA and 0.1 mM phenylmethylsulphonyl fluoride) and separation of the cytosol and heavy membrane fraction (containing mitochondria and ER) was performed as previously reported<sup><a href="#B6">6</a></sup>. A cytosolic fraction (20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g protein) and 1 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of membrane fraction (out of 50 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l total) were analysed by western blotting with an anti-cytochrome <i>c</i> antibody (dilution 1:1000; BD-Pharmingen (San Diego, CA).</span><br xmlns=""><br xmlns=""><a xmlns="" name="Immunoprecipitation"></a><span xmlns="" class="articletext"><b>Immunoprecipitation</b></span><br xmlns=""><span xmlns="" class="articletext">Endogenous protein: HEK293T (10<sup>7</sup> cells) were lysed in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Chaps buffer (150 mM NaCl, 10 mM Hepes at pH 7.4 and 1.0% Chaps) containing protease inhibitors (100 times dilution of Protease Inhibitors Cocktail; Sigma, St Louis, MO) according to the previously reported method<sup><a href="#B11">11, 
</a></sup><sup><a href="#B12">12, 
</a></sup><sup><a href="#B16">16</a></sup>. After preclearing of 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of the sample with 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Protein A&#150;Sepharose (CL-4B, 17-0780-01; Amersham, Piscataway, NJ) at 4 &#176;C for 1 h, immunoprecipitations were performed by incubating 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of lysates with 2 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of anti-Bax polyclonal (Cat. #13666E, BD-Pharmingen) or anti-Ku70 monoclonal antibody (Cat. #69141A, BD-Pharmingen) at 4 &#176;C for 2 h. In some cases, 2 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of anti-Bax monoclonal antibody (clone 6A7, BD-Pharmingen) was used to detect the active form of Bax. Immunocomplex in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l lysates was precipitated by 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Protein G&#150;Sepharose. After extensive washing in buffer, beads were boiled in 40 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Laemmli buffer and 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of the eluted proteins were resolved by SDS&#150;PAGE.</span><br xmlns=""><br xmlns=""><span xmlns="" class="articletext">Co-precipitation of biotin-labelled peptides and endogenous Bax with Streptavidin beads: HEK293T cells (10<sup>7</sup> cells) lysed in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l Chaps-based buffer were incubated with biotin-labelled NC peptide or VPMLK (V5) peptide for 1 h. The concentrations of NC and V5 peptide labelled with biotin are described in the figure legends. Coprecipitation was performed with 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Streptavidin beads (Amersham Pharmacia Biotech). Flag-tagged-Ku70 and endogenous Bax: HEK293T cells (10<sup>7</sup> cells) were transfected with 10 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of pCMV-2B-control vector (Flag-tagged firefly luciferase), pCMV-2B-Ku70<sup>wt</sup> (Flag&#150;Ku70wt), pCMV-2B-Ku70<sup>1&#150;577</sup> (Flag&#150;Ku70<sup>1&#150;577</sup>) or pCMV-2B-Ku70<sup>578&#150;609</sup>(Flag&#150;Ku70<sup>578&#150;609</sup>) in the presence of 50 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M z-VAD-fmk. Co-immunoprecipitation was performed with anti-Flag monoclonal antibody (Cat. #200472, Stratagene; 2 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g for 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l sample) and western blot analysis of Bax (15% SDS&#150;PAGE) was performed with anti-human Bax polyclonal antibody (BD-Pharmingen).</span><br xmlns=""><br xmlns=""><a xmlns="" name="Subcellular fractionation"></a><span xmlns="" class="articletext"><b>Subcellular fractionation</b></span><br xmlns=""><span xmlns="" class="articletext">One day after treatment, cells (10<sup>7</sup> cells) were homogenized with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of ice-cold homogenization buffer (250 mM sucrose, 20 mM Hepes at pH 7.5, 10 mM potassium chloride, 1.5 mM magnesium chloride, 1 mM EDTA and 0.1 mM phenylmethylsulphonyl fluoride). Subcellular fractionation was performed as reported<sup><a href="#B6">6</a></sup>, together with the confirmation of each fraction with appropriate marker proteins (cytosolic fraction, Lactate dehydrogenase (LDH) with anti-human LDH antibody (Cat. #L7016, Sigma); nucleus fraction, Proliferating cell nuclear antigen (PCNA) with anti-PCNA antibody (Cat. #NA03, Oncogene); mitochondria containing heavy membrane fraction, F1-ATPase <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">-subunit (F1<img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">) with anti-F1<img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha"> subunit antibody (Cat. #A-11144, Molecular Probes). For total cell lysates, samples were prepared with ice-cold lysis buffer (containing 50 mM sodium chloride, 25 mM Hepes at pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l<sup>-1</sup> E-64 and 1% Triton X-100). In some experiments, samples containing 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of protein from total cell lysates or cytosolic fraction were subjected to western blot analysis of Bax or Ku70. The pellets of the fractions of heavy membrane and nucleus were dissolved in 50 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Laemmli buffer and the same proportion of the volume equal to that of the cytosol samples out of its total volume was used for western blot analysis.</span><br xmlns=""><br xmlns=""><a xmlns="" name="Fluorescence microscopy"></a><span xmlns="" class="articletext"><b>Fluorescence microscopy</b></span><br xmlns=""><span xmlns="" class="articletext">HeLa cells and DU145 cells (10<sup>6</sup> cells; untransfected or transfected with pcDNA3-Bax) were incubated with 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">M FITC-labelled VPMLK (V5) peptide for 1 h before microscopic analysis. For immunostaining, cells incubated with FITC&#150;V5 peptide for 1 h were fixed with 4% paraformaldehyde in PBS. Cells were permeablized with 0.5% Triton X-100 and 0.05% Tween-20 in PBS. Fixed cells were incubated in PBS containing 5% BSA at 37 &#176;C and stained with anti-Bax monoclonal antibody (BD-Pharmingen; dilution 1:50) followed by detection of Texas-Red-labelled anti-mouse IgG (Jackson ImmunoResearch, dilution 1:100).</span><br xmlns=""><br xmlns=""><a xmlns="" name="Scatchard analysis of FITC|[ndash]|V5|[ndash]|Bax binding"></a><span xmlns="" class="articletext"><b>Scatchard analysis of FITC&#150;V5&#150;Bax binding</b></span><br xmlns=""><span xmlns="" class="articletext">Ku70-deficient MEFs (10<sup>7</sup> cells) were lysed in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of detergent-free hypotonic buffer (hypotonic (5 mM sodium chloride) PBS at pH 7.4) containing protease inhibitors (100 times dilution of Protease Inhibitors Cocktail; Sigma) according to the previously reported method<sup><a href="#B11">11, 
</a></sup><sup><a href="#B12">12</a></sup>. For Scatchard analysis, the cytosol fraction was used and sodium chloride was added to prepare the isotonic condition before immunoprecipitation, as previously reported<sup><a href="#B11">11, 
</a></sup><sup><a href="#B12">12</a></sup>. After incubating the sample with various concentrations of FITC-labelled VPMLK (V5) peptide at 37 &#176;C for 1 h, immunoprecipitations were performed under detergent-free conditions at 37 &#176;C by incubating 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of lysates with 2 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of anti-Bax polyclonal antibody (Cat. #13686E, BD-Pharmingen) for 2 h. Immunocomplex in 200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l lysates was precipitated by 20 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l of Protein-A&#150;Sepharose. FITC fluorescence of pre-immunoprecipitation (B + F) and the supernatant after immunoprecipitation (F) were measured by fluorescence microplate reader (Molecular Devices, Sunnyvale, CA), and the values of B+F and B were calculated. <i>K</i><sub>d</sub> was calculated by Scatchard plot. For control experiment, immunodepletion of Bax was performed before incubation of FITC&#150;V5 and cell lysates. Cell lysates (200 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">l) were mixed with 4 <img border=0 src="/__chars/mu/black/med/base/glyph.gif" align="middle" alt="mu">g of anti-Bax antibody and incubated at 37 &#176;C for 2 h for immunodepletion of Bax. No significant binding of FITC&#150;V5 to cellular components was detected in Bax-immunodepleted samples.</span><br xmlns=""><br xmlns=""><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="470"><tr><td rowspan="2" height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td><td align="right"><img alt="" height="3" width="5" src="/ncb/images/arrow_black_up.gif">&nbsp;<a class="top" href="#top">Top</a></td></tr><tr><td height="7" align="right"><img alt="" height="7" width="1" src="/images/spacer.gif"></td></tr><tr><td colspan="2" height="1"><img alt="" height="1" width="470" src="/ncb/images/spacer_grey.gif"></td></tr><tr><td colspan="2" height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr></table><span xmlns="" class="articletext">Received 25 September 2002; </span><span xmlns="" class="articletext">Accepted 21 February 2003; </span><span xmlns="" class="articletext">Published online 24 March 2003.</span><br xmlns=""><br xmlns=""><a xmlns="" name="References"></a><span xmlns="" class="heading3">REFERENCES </span><ol xmlns="" class="articletext"><li><A name="B1"></a>
Green, D.R. &amp; Reed, J.C. Mitochondria and apoptosis. <i>Science</i> <b>281</b>, 1309&#150;1312 (1998).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1126%2FSCIENCE.281.5381.1309" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=9721092&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000075666800039&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1cXlvVegsLo%3D&pissn=1465-7392&pyear=2003&md5=1e1e951115e1d95e4fb4f494329cd293" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B2"></a>
Gross, A., McDonnell, J.M. &amp; Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. <i>Genes Dev</i> <b>13</b>, 1899&#150;1911 (1999).&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10444588&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000081971900001&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1MXltlGktrg%3D&pissn=1465-7392&pyear=2003&md5=1d3cbee00a87be5af1fccedcac8ad227" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B3"></a>
Wei, M.C. <i>et al</i>. Pro-apoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. <i>Science</i> <b>292</b>, 727&#150;730 (2001).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1126%2Fscience.1059108" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=11326099&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000168478300051&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3MXjt1eltr0%3D&pissn=1465-7392&pyear=2003&md5=1b2092a721a901193282a42e73448b58" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B4"></a>
Wolter, K.G. <i>et al</i>. Movement of Bax from the cytosol to mitochondria during apoptosis. <i>J. Cell Biol.</i> <b>139</b>, 1281&#150;1292 (1997).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1083%2FJCB.139.5.1281" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=9382873&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=A1997YK65800018&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK2sXnvFeqsLg%3D&pissn=1465-7392&pyear=2003&md5=d0d1abf8b41a6e686259d12700188ac8" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B5"></a>
Walker, J.R., Corpina, R.A. &amp; Goldberg, J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. <i>Nature</i> <b>412</b>, 607&#150;614 (2001).&nbsp;|&nbsp;<a href="/doifinder/10.1038%2F35088000" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=11493912&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000170318000032&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3MXmtVCisLs%3D&pissn=1465-7392&pyear=2003&md5=d448dc44ea7ce81319cb8ff9554657ce" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B6"></a>
Sawada, M. <i>et al</i>. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. <i>Nature Cell Biol.</i> <b>5</b>, 320&#150;329 (2003).&nbsp;|&nbsp;<a href="/doifinder/10.1038%2Fncb950" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=12652308&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000182080700015&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3sXisFWrt7k%3D&pissn=1465-7392&pyear=2003&md5=87aa97b6c18e7f966c284cfdfc7af33b" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B7"></a>
Zhang, Z. <i>et al</i>. The three-dimensional structure of the C-terminal DNA-binding domain of human Ku70. <i>J. Biol. Chem.</i> <b>276</b>, 38231&#150;38236 (2001).&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=11457852&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000171526500069&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3MXotFOqsr8%3D&pissn=1465-7392&pyear=2003&md5=820b061d4920d623990e6667ee9164a5" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B8"></a>
Ashkenazi, A. &amp; Dixit, V.M. Death receptors: signaling and modulation. <i>Science</i> <b>281</b>, 1305&#150;1308 (1998).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1126%2Fscience.281.5381.1305" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=9721089&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000075666800038&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1cXlvVegsL0%3D&pissn=1465-7392&pyear=2003&md5=ad98ee6e4d6ed5f8b9104d45c29a4cb5" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B9"></a>
Matsuyama, S., Llopis, J., Deveraux, Q.L., Tsien, R.Y. &amp; Reed, J.C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. <i>Nature Cell Biol.</i> <b>2</b>, 318&#150;325 (2000).&nbsp;|&nbsp;<a href="/doifinder/10.1038%2F35014006" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10854321&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000087454000012&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3cXlt1Sls70%3D&pissn=1465-7392&pyear=2003&md5=b182241df8aaf3e633bc05b76122e39f" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B10"></a>
Suzuki, M., Youle, R.J. &amp; Tjandra, N. Structure of Bax: coregulation of dimer formation and intracellular localization. <i>Cell</i> <b>103</b>, 645&#150;654 (2000).&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=11106734&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000165348000009&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3cXot1Gnu7c%3D&pissn=1465-7392&pyear=2003&md5=22329759002e4d755156289cef489dae" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B11"></a>
Hsu, Y.T. &amp; Youle, R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. <i>J. Biol. Chem.</i> <b>273</b>, 10777&#150;10783 (1998).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1074%2FJBC.273.17.10777" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=9553144&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000073224200093&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1cXivFKms74%3D&pissn=1465-7392&pyear=2003&md5=6ec419ced92c521559757d9043d912c3" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B12"></a>
Nechushtan, A., Smith, C.L., Hsu, Y.T. &amp; Youle, R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. <i>EMBO J.</i> <b>18</b>, 2330&#150;2341 (1999).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1093%2Femboj%2F18.9.2330" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10228148&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000080251600003&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1MXjtlKhsro%3D&pissn=1465-7392&pyear=2003&md5=09791fe49492e348addb62e4ab1f828e" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B13"></a>
Vila, M. <i>et al</i>. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4- phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. <i>Proc. Natl Acad. Sci. USA</i> <b>98</b>, 2837&#150;2842 (2001).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1073%2Fpnas.051633998" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=11226327&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3MXhslKmtLc%3D&pissn=1465-7392&pyear=2003&md5=601f49c934feefe2d8a7ddc5d8dde3bb" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B14"></a>
Selznick, L.A., Zheng, T.S., Flavell, R.A., Rakic, P. &amp; Roth, K.A. Amyloid <img border=0 src="/__chars/beta/black/med/base/glyph.gif" align="middle" alt="beta">-induced neuronal death is bax-dependent but caspase-independent. <i>J. Neuropathol. Exp. Neurol.</i> <b>59</b>, 271&#150;279 (2000).&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10759182&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000086280100002&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DC%2BD3cXisleis70%3D&pissn=1465-7392&pyear=2003&md5=9083aaaee795dcc42f64192a01b31d11" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B15"></a>
Korsmeyer, S.J. BCL-2 gene family and the regulation of programmed cell death. <i>Cancer Res.</i> <b>59</b>, 1693s&#150;1700s (1999).&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=10197582&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000079582000006&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1MXisVWrsrk%3D&pissn=1465-7392&pyear=2003&md5=738e5ce0f333f1471c4ff6df497f363e" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li>
<li><A name="B16"></a>
Matsuyama, S., Schendel, S.L., Xie, Z. &amp; Reed, J.C. Cytoprotection by Bcl-2 requires the pore-forming <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">5 and <img border=0 src="/__chars/alpha/black/med/base/glyph.gif" align="bottom" alt="alpha">6 helices. <i>J. Biol. Chem.</i> <b>273</b>, 30995&#150;31001 (1998).&nbsp;|&nbsp;<a href="http://dx.doi.org/10.1074%2Fjbc.273.47.30995" target="external">Article</a>&nbsp;|&nbsp;<a 
href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=9812996&dopt=Abstract" target="external"><span 
class="intlink">PubMed</span></a> &nbsp;|&nbsp;<a href="http://links.isiglobalnet2.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=Nature&SrcApp=Nature&DestLinkType=FullRecord&KeyUT=000077136900024&DestApp=WOS_CPL" target="external">ISI</a>&nbsp;|&nbsp;<a href="http://chemport.cas.org/cgi-bin/sdcgi?APP=ftslink&action=reflink&origin=npg&version=1.0&coi=1:CAS:528:DyaK1cXns1egt7Y%3D&pissn=1465-7392&pyear=2003&md5=46254fd85aa7b5de9a18200443014750" target="external" alt="Chemical 
Abstracts Service">ChemPort</a>&nbsp;|</li></ol><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="470"><tr><td rowspan="2" height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td><td align="right"><img alt="" height="3" width="5" src="/ncb/images/arrow_black_up.gif">&nbsp;<a class="top" href="#top">Top</a></td></tr><tr><td height="7" align="right"><img alt="" height="7" width="1" src="/images/spacer.gif"></td></tr><tr><td colspan="2" height="1"><img alt="" height="1" width="470" src="/ncb/images/spacer_grey.gif"></td></tr><tr><td colspan="2" height="20"><img alt="" height="20" width="1" src="/images/spacer.gif"></td></tr></table><a xmlns="" name="Acknowledgments"></a><span xmlns="" class="heading3">Acknowledgments</span><br xmlns=""><span xmlns="" class="articletext">We thank D.A. Boothman for critical reviewing of the manuscript and encouragement. This work was supported in part by the Blood Center Research Foundation, Northwest Mutual Foundation, American Society of Hematology (Junior Faculty Award) to S.M.</span><br xmlns=""><br xmlns=""><p xmlns="" class="articletext"><b>Competing interests statement:</b>&nbsp;
The authors declare that they have no competing financial interests.</p></td></tr></table></td><td width="15"><img alt="" height="1" width="15" src="/images/spacer.gif"/></td><td valign="top" width="130"><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="130"><tr><td><img alt="" height="34" width="1" src="/images/spacer.gif"></td></tr><tr><td colspan="2" height="22"><img alt="" height="22" width="1" src="/images/spacer.gif"></td></tr><tr><td colspan="2" class="whitesml" height="20" bgcolor="#546D9F" align="center"><b>FULL  TEXT</b></td></tr><tr><td valign="middle" colspan="2" bgcolor="#DFE9FD" height="17" align="center" class="blacksml2"><table cellpadding="1" cellspacing="0" border="0" width="106"><tr><td width="3"><img border="0" alt="" height="5" width="3" src="/ncb/images/arrow_black_prev.gif"></td><td width="100" align="center"><a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/full/ncb954.html">Previous</a><a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/full/ncb956.html"> | Next</a></td><td height="10" width="3"><img alt="" height="5" width="3" src="/ncb/images/arrow_black.gif"></td></tr></table></td></tr><tr><td colspan="2"><img alt="" height="1" width="130" src="/ni/images/spacer.gif"></td></tr><tr><td width="15" bgcolor="#DFE9FD" height="15" align="center" class="blacksml2"><img alt="" border="0" height="5" width="3" src="/ncb/images/arrow_black.gif"></td><td width="115" bgcolor="#DFE9FD" height="17" class="blacksml2"><a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/index.html">Table of contents</a></td></tr><tr><td colspan="2" height="15" align="center" class="blacksml2"><table cellpadding="1" cellspacing="0" border="0" width="130"><tr><td bgcolor="#DFE9FD"><table cellpadding="0" cellspacing="0" border="0" width="128"><tr><td colspan="2" align="center" bgcolor="#FFFFFF"><img alt="" height="5" width="1" src="/images/spacer.gif"></td></tr><tr><td width="23" align="center" bgcolor="#FFFFFF"><img alt="Download PDF" height="14" width="14" src="/ncb/images/icon_pdf.gif"></td><td height="14" width="105" bgcolor="#FFFFFF"><a class="breadcrumblink" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v5/n4/full/ncb955.html&filetype=pdf">Download PDF</a></td></tr><tr><td valign="middle" colspan="2" align="center" bgcolor="#FFFFFF"><img alt="" height="6" width="1" src="/images/spacer.gif"></td></tr><tr><td valign="middle" width="23" align="center" bgcolor="#FFFFFF"><img alt="Send to a friend" height="10" width="13" src="/ncb/images/icon_email.gif"></td><td valign="middle" height="12" width="105" bgcolor="#FFFFFF"><a class="breadcrumblink" onclick="mailafriend('0','/ncb/sendfriend/sendfriend_form.html','600','600')" href="javascript:void(0)">Send 
to a friend</a></td></tr><tr><td valign="middle" colspan="2" align="center" bgcolor="#FFFFFF"><img alt="" height="5" width="1" src="/ni/images/spacer.gif"></td></tr></table></td></tr></table></td></tr><table cellpadding="0" cellspacing="0" border="0" width="130"><tr><td height="10"><img alt="" height="1" width="15" src="/ni/images/spacer.gif"></td><td height="10"><img alt="" height="1" width="115" src="/ni/images/spacer.gif"></td></tr><tr><td align="center" width="15" class="blacksml2"><img alt="" border="0" height="3" width="5" src="/ncb/images/arrow_black_dwn.gif"></td><td height="15" width="115" class="blacksml2"><a class="breadcrumblink" href="#Methods">Methods</a></td></tr><tr><td align="center" width="15" class="blacksml2" valign="top"><img alt="" vspace="4" border="0" height="5" width="3" src="/ncb/images/arrow_black.gif"></td><td height="15" width="115" class="blacksml2"><a class="breadcrumblink" href="javascript:void(0)" onClick="window.open('/ncb/journal/v5/n4/fig_tab/ncb955_ft.html','fig_tab','width=600,height=400,scrollbars=yes')">Figures &amp; Tables</a></td></tr><tr><td align="center" width="15" class="blacksml2"><img alt="" border="0" height="3" width="5" src="/ncb/images/arrow_black_dwn.gif"></td><td height="15" width="115" class="blacksml2"><a class="breadcrumblink" href="#Acknowledgments">Acknowledgments</a></td></tr><tr><td align="center" width="15" class="blacksml2"><img alt="" border="0" height="3" width="5" src="/ncb/images/arrow_black_dwn.gif"></td><td height="15" width="115" class="blacksml2"><a class="breadcrumblink" href="#References">References</a></td></tr><tr><td valign="top" align="center" width="15" class="blacksml2"><img alt="" vspace="4" border="0" height="5" width="3" src="/ncb/images/arrow_black.gif"></td><td height="15" width="115" class="blacksml2"><a href="/ncb/journal/v5/n4/suppinfo/ncb955_S1.html" target="_blank" class="breadcrumblink">Supplementary info</a></td></tr><tr><td align="center" colspan="2" class="blacksml2"><img alt="" height="5" width="1" src="/images/spacer.gif"></td></tr><tr><td align="center" colspan="2" class="blacksml2"><img alt="" height="1" width="130" src="/ncb/images/spacer_grey.gif"></td></tr><tr><td class="blacksml2" width="15" align="center"><img src="/images/arrow_black.gif" width="3" height="5" border="0" alt=""></td><td class="blacksml2" width="115" height="15"><a href="/ncb/journal/v5/n4/ris/ncb955.ris" target="_blank" class="breadcrumblink">Export citation</a></td></tr><tr><td class="blacksml2" width="15" align="center"><img src="/images/arrow_black.gif" width="3" height="5" border="0" alt=""></td><td class="blacksml2" width="115" height="15"><a href="/ncb/journal/v5/n4/ris/ncb955refs.ris" target="_blank" class="breadcrumblink">Export references</a></td></tr><tr><td align="center" colspan="2" class="blacksml2"><img alt="" height="5" width="1" src="/images/spacer.gif"></td></tr>
 <SCRIPT>
 var show = '536';
 if(show > 0)
 {
 document.write('<tr>');
 document.write('<td class="blacksml2" width="15" align="center">');
 document.write('<img src="/ncb/images/arrow_black.gif" width="3" height="5" border="0" alt="">');
 document.write('</td>');
 document.write('<td class="blacksml2" width="115" height="15">');
 }
 </SCRIPT>
       <A class="breadcrumblink" HREF="javascript:void(0)" onclick="window.open('http://sherman.nature.com/arls/Query?prod=NCB&query=http%3A//www.nature.com/doifinder/10.1038/ncb955&type=LE&src_title=Cytoprotective%20membrane-permeable%20peptides%20designed%20from%20the%20Bax-binding%20domain%20of%20Ku70&src_jrnl=Nature%20Cell%20Biology&src_vol=5&src_pp=352-357&src_date=2003&target=popup', 'autonomypopup', 'resizeable=yes,scrollbars=yes,scrolling=yes,statusbar=no,navbar=no,width=550,height=550');return false;">More articles like this</A>
   <SCRIPT>
	if(show > 0){
	   document.write('</td>');
	   document.write('</tr>');
	   document.write('<tr>');
	   document.write('<td height="5" align="center" colspan="2" class="blacksml2"><img alt="" height="5" width="1" src="/nsmb/images/spacer.gif"></td>');
	   document.write('</tr>');
	   document.write('<tr>');
	   document.write('<td align="center" colspan="2" class="blacksml2"><img alt="" height="1" width="130" src="/ncb/images/spacer_grey.gif"></td>');
	   document.write('</tr>');

	}
   </SCRIPT><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td height="30" align="center">&nbsp;</td></tr><tr><td align="center"><span class="greysml">ADVERTISEMENT</span></td></tr><tr><td><img alt="" height="3" width="1" src="/ni/images/spacer.gif"></td></tr><tr><td align="center"><script type="text/javascript" language="javascript">
<!--
document.write ('<ILAYER HEIGHT="600" WIDTH="120" VISIBILITY="hidden" ID="layer2"></ILAYER>');
document.write ('<NOLAYER>');
document.write ('<IFRAME scrolling="no" frameborder="0" vspace="0" hspace="0" marginheight="0" marginwidth="0" height="600" width="120" SRC="http://ad.doubleclick.net/adi/cellbio.nature.com/curr_back;pos=right;' + adinf + ';sz=120x600;ord=' + ordval + '?">');
document.write ('<A HREF="http://ad.doubleclick.net/jump/cellbio.nature.com/curr_back;pos=right;abr=!ie4;abr=!ie5;' + adinf + 'sz=120x600;ord=' + ordval + '?"></A>');
document.write ('<IMG alt="advertisement" align="center" HSPACE="0" HEIGHT="600" WIDTH="120" BORDER="0" SRC="http://ad.doubleclick.net/ad/cellbio.nature.com/curr_back;pos=right;abr=!ie4;abr=!ie5;' + adinf + 'sz=120x600;ord=' + ordval + '?"></IFRAME>');
document.write ('</NOLAYER>');
// --></script><noscript><a href="http://ad.doubleclick.net/jump/cellbio.nature.com/curr_back;pos=right;abr=!NN2;sz=120x600;ord=07893195?"><img alt="advertisement" height="600" width="120" border="0" src="http://ad.doubleclick.net/ad/cellbio.nature.com/curr_back;pos=right;abr=!NN2;sz=120x600;ord=07893195?"></a></noscript></td></tr></table></table></table></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="0" border="0" width="100%"><tr><td align="center">&nbsp;</td></tr><tr><td height="4" align="center" bgcolor="#546D9F"><img alt="" height="4" width="1" src="/images/spacer.gif"></td></tr><tr><td align="center"><table cellpadding="0" cellspacing="0" border="0" width="760"><tr><td colspan="2" valign="top"><img alt="" height="10" width="1" src="/images/spacer.gif"></td></tr><tr><td width="145" valign="top"><a href="/ncb/"><img height="41" width="128" border="0" alt="Nature Cell Biology" src="/includes/rj_globnavimages/ncb_footer_logo.gif"></a><br><span class="blacksmltext">
ISSN:&nbsp;1465-7392<br>
EISSN:&nbsp;1476-4679</span></td><td class="blacknorm" width="615" valign="top"><a class="footer" href="/ncb/index.html">Journal home</a> | <a class="footer" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/vaop/ncurrent/index.html">Advance online publication</a> | <a class="footer" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v6/n3/index.html">
Current issue
</a> | <a class="footer" href="/cgi-taf/DynaPage.taf?file=/ncb/archive/index.html">Archive</a> | <a class="footer" href="/ncb/press_release/index.html">Press releases</a> | 
<a class="footer" href="/ncb/supplements/index.html">Supplements</a> | <a class="footer" href="/ncb/webfocus/index.html">Focuses</a> | <a class="footer" href="/ncb/image/index.html">Cell of the month</a> | 
<a class="footer" href="/ncb/authors/index.html">For authors</a> | <a class="footer" href="http://mts-ncb.nature.com" target="_blank">Online submission</a> | <a class="footer" href="http://npg.nature.com/npg/servlet/Content?data=xml/01_reprints.xml&amp;style=xml/01_reprints.xsl" target="_blank">Permissions</a> | <a class="footer" href="/ncb/referees/index.html">For referees</a> | <a class="footer" href="/cgi-taf/DynaPage.taf?file=/ncb/journal/v6/n1/index.html">Free online issue</a> | <a class="footer" href="/ncb/about/index.html">About the journal</a> | <a class="footer" href="/ncb/contact/index.html">Contact the journal</a> | <a class="footer" href="/registration/index.taf?site_source=ncb" target="_blank">Subscribe</a> | <a class="footer" href="http://advertising.nature.com" target="_blank">Advertising</a> | <a class="footer" href="http://npg.nature.com/npg/forms/03_current.jsp">work@npg</a> | <a class="footer" href="http://www.naturereprints.com" target="_blank">naturereprints</a> | <a class="footer" href="/ncb/site/index.html">About this site</a> | <a class="footer" href="http://npg.nature.com/npg/servlet/Content?data=xml/07_home.xml&amp;style=xml/07_home.xsl" target="_blank">For librarians</a>
</td></tr><tr><td colspan="2" valign="top"><img alt="" height="10" width="1" src="/images/spacer.gif"></td></tr></table></td></tr><tr><td height="2" align="center" bgcolor="#546D9F"><img alt="" height="2" width="1" src="/images/spacer.gif"></td></tr><tr><td align="center"><table xmlns="" cellpadding="0" cellspacing="0" border="0" width="760"><tr><td colspan="3" valign="top"><img alt="" height="10" width="1" src="/includes/rj_globnavimages/spacer.gif"></td></tr><tr><td align="right" width="130" valign="top"><a href="http://npg.nature.com/npg/servlet/Content?data=xml/02_welcome.xml&style=xml/02_welcome.xsl"><img border="0" alt="Nature Publishing Group, publisher of Nature, and other science journals and reference works" height="26" width="26" src="/includes/rj_globnavimages/npg_footer_logo.gif"></a></td><td align="right" width="15" valign="top"><img alt="" height="1" width="15" src="/includes/rj_globnavimages/spacer.gif"></td><td class="blacksmltext" width="615" valign="middle"><a href="/copyright/copyright_ncb.html" onClick="window.open('/copyright/copyright_ncb.html','copyright_window','toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=no,resizable=no,copyhistory=yes,width=450,height=280,top=380,left=20');return false;" class="copyright">&copy;2003&nbsp;Nature Publishing Group</a> | <a target="_blank" class="privacy" href="http://npg.nature.com/npg/servlet/Content?data=xml/08_privacy.xml&style=xml/08_privacy.xsl">Privacy policy</a></td></tr><tr><td colspan="3" valign="top"><img alt="" height="10" width="1" src="/includes/rj_globnavimages/spacer.gif"></td></tr></table></td></tr></table><script type="text/javascript" language="javascript">
<!--
document.writeln ('<layer src="http://ad.doubleclick.net/adl/cellbio.nature.com/curr_back;pos=top;dcopt=ist;' + adinf + 'sz=468x60;ord=' + ordval + '?" visibility="hidden" width="468" height="60" onload="moveToAbsolute(layer1.pageX,layer1.pageY);clip.height=60;clip.width=468;visibility=\'show\';"></layer>');
// -->
</script><script type="text/javascript" language="javascript">
<!--
document.writeln ('<layer SRC="http://ad.doubleclick.net/adl/cellbio.nature.com/curr_back;pos=right;' + adinf + 'sz=120x600;ord=' + ordval + '?" visibility="hidden"  width="120" height="600" onload="moveToAbsolute(layer2.pageX,layer2.pageY);clip.height=600;clip.width=120;visibility=\'show\';"></layer>');
// -->
</script></body></html>